|Date:||November 10, 2016 | 9:00 am – 5:00 pm
November 11, 2016 | 8:30 am – 2:00 pm
|Location:||The Menger Hotel
204 Alamo Plaza
San Antonio, TX 78205
Dr. Arvin’s principal research interests are the human herpes viruses and childhood viral diseases and vaccines. Her basic laboratory research focuses on varicella zoster virus (VZV), a herpes virus that causes chicken pox and herpes zoster (shingles). She has performed extensive basic work on the molecular mechanisms of VZV pathogenesis and the host immune response, and carried out early studies of a VZV vaccine that is now licensed for the prevention of chicken pox and zoster.
Dr. Arvin received her M.D. from the University of Pennsylvania.
Dr. Estes’ research involves the molecular biology of gastrointestinal viruses. Her lab uses viruses that infect distinct types of cells (enterocytes, crypt cells, M cells) in the GI tract as probes to learn about the biology, host response and gene expression of these cells. They are using multidisciplinary approaches to probe the structure and molecular biology of GI viruses to understand the basic mechanisms that control virus replication, morphogenesis, virus-host interactions, and pathogenesis.
Dr. Estes received her Ph.D. from the University of North Carolina.
Dr. Murre’s lab studies gene regulation in adult stem cells and developing lymphocytes. Both global and single cell strategies are being utilized with the aim to describe normal development as well as aged and diseased states in molecular terms. The lab has a long-standing interest in deciphering the role and regulation of helix-loop-helix proteins in lymphocyte development. This class of factors plays key roles in hematopoiesis. Currently, his main interests are in the role of these factors in the control of hematopoietic stem cell homeostasis, B- and T-lineage specification and commitment, aging, inflammatory disease and their roles in the periphery in the response to invading pathogens.
Dr. Murre performed his graduate work at Harvard Medical School and was a postdoctoral fellow at MIT. He is a Searle Scholar and the recipient of the National Institutes of Health Merit Award.
Dr. Pier conducts research on bacterial pathogenesis, host immune responses, and vaccine development, with the major focus being the role of bacterial capsules in pathogenesis and as antigenic targets for vaccines. His current research encompasses Pseudomonas aeruginosa, Staphylococcus aureus, and a large number of microbes, including Escherichia coli, Yersinia pestis, Bordetella spp., and others that have been found, along with staphylococci, to produce a surface polysaccharide termed poly-N-acetyl glucosamine (PNAG). PNAG vaccines and immunotherapies constitute a large area of interest in his lab’s ongoing research activities.
Dr. Pier received his Ph.D. in microbiology from the University of California at Berkeley.